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Date: January 31, 2013  
 
Dear Patient Education and Counseling Journal Reviewers, 
 
Please accept for review a new study titled “Motivational interviewing in medical care 
settings: A systematic review and meta-analysis of randomized controlled trials.” 
 
We believe the manuscript is well suited to this outlet as its focus is on behavioral 
approaches to promoting patients’ health. The manuscript is not under review elsewhere. 
Preliminary findings were presented at a research meeting on Motivational Interviewing held in 
Venice, Italy on June 18
th
, 2012.  
 
We followed the PRISMA guidelines in both conducting the study and reporting the 
results.  
 
In its current form, the manuscript is 4,922 words in length with an abstract of 194 words. 
The manuscript has 6 tables and 2 figures (plus an optional figure that we could include if the 
manuscript is deemed appropriate for your journal).   
 
We believe that there is a compelling rationale for our study and that its publication 
should be timely. As clinicians, policy makers and governments emphasize the importance of 
patients’ lifestyle factors, behavior change counseling (like Motivational Interviewing; MI) is 
being heavily promoted for use in health care settings throughout the world. We believe that this 
unique meta-analytic review should be published in your journal because it fills a crucial gap in 
the evidence base and will guide policy and practice. This is the first time that the evidence about 
the use of MI across medical care settings exclusively has been systematically identified and 
subjected to meta-analysis, and the results allow estimates of the relative advantage of MI over 
Cover letter
comparison interventions as well as demonstrate the wide range of target behaviors to which MI 





Brad Lundahl, PhD 
Licensed Psychologist 
Associate Professor 
College of Social Work 
University of Utah 
Salt Lake City, Utah  84112 
Brad.Lundahl@socwk.utah.edu 
July 17, 2013 
 
TO:  Dr. Arnstein Finset, Editor-in-Chief, 
Patient Education and Counseling 
 
RE:  Second set of Reference Notes regarding resubmission of “PEC-13-88: Title:  
 Motivational interviewing in medical care settings: A systematic review and meta- 
 analysis of randomized controlled trials”  
 





Thank you for your revised submission. One of the original reviewers has commented on your 
revisions. The reviewer found that you had altered the text in a manner that accommodated the 
previously stated concerns, but indicated that the new introductory paragraph did not add much 
to the paper. I agree that the paragraph is somewhat displaced right at the beginng, but will 
suggest that you try to find a room for it towards the end of the Introduction (or skip it altogether 
if you are more comfortable with that). 
ALSO: Reviewer #2: I do not feel that the new introductory paragraph adds to the paper. 
I recommend removing it. However, I think the additional changes improved the clarity 
of the manuscript. Nice work. 
 
OUR RESPONSE:  
Thank you for your feedback. We agree that the new introductory paragraph did not add much 
and it has been fully removed from the paper.  
 
EDITOR COMMENTS: 
I am happy to say that your paper may now be accepted for publication as soon as this minor 
detail has been attended to. 
OUR RESPONSE: 
We are delighted and hope the manuscript has an impact. Thank you for your efforts on our 
behalf! 
Response to Reviewers Comments
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Motivational Interviewing (MI) is a method for encouraging people to make behavioral changes 
to improve health outcomes. We used systematic review and meta-analysis to investigate MI's 
efficacy in medical care settings.  
Methods   
Database searches located randomized clinical trials that compared MI to comparison conditions 
and isolated the unique effect of MI within medical care settings.   
Results  
Forty-eight studies (9,618 participants) were included. The overall effect showed a statistically 
significant, modest advantage for MI: Odd Ratio = 1.55 (CI: 1.40 to 1.71), z = 8.67, p < .001. MI 
showed particular promise in areas such as HIV viral load, dental outcomes, death rate, body 
weight, alcohol and tobacco use, sedentary behavior, self-monitoring, confidence in change, and 
approach to treatment. MI was not particularly effective with eating disorder or self-care 
behaviors or some medical outcomes such as heart rate. MI was robust across moderators such as 
delivery location and patient characteristics, and appears efficacious when delivered in brief 
consultations.  
Conclusion & Practice Implications 
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The emerging evidence for MI in medical care settings suggests it provides a moderate 
advantage over comparison interventions and could be used for a wide range of behavioral issues 
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1. Introduction   
Unhealthy eating, smoking, excessive drinking, and lack of exercise are among the most 
important modifiable causes of health care problems in the developed world (1, 2). As medical 
care increasingly focuses on managing long-term conditions, clinicians have a growing need to 
motivate patients to make lifestyle changes that modify risk factors and optimize adherence to 
medical advice (3).  
One counseling approach for promoting behavior change in medical care is MI, defined as ―a 
person-centered counseling style for addressing the common problem of ambivalence about 
change.‖ (4) MI arose from efforts to start difficult conversations with patients about risky 
alcohol intake (5). The inclination to confront or persuade patients was replaced by evoking 
clients‘ own reasons to change, which minimized resistance (6). Later innovations focused on 
people‘s natural use of language about change and how listening skills might evoke such 
language (7). MI is both flexible and robust, producing desirable outcomes across many problem 
areas in different formats (4). That is, MI can focus on a variety of problem behaviors—typically 
one at a time—and can be delivered in a single session or through multiple sessions, including as 
a prelude to other treatments (e.g., inpatient care), integrated with other treatments (e.g., 
cognitive behavior therapy), or as a stand-alone intervention. 
The relevance of MI to health care settings emerged in studies on providing feedback of medical 
test results (8, 9). Whereas MI is patient-centered, it is also directional in its focus on change 
targets, including health behaviors. Refinements to suit health care consultation therefore 
emerged along with outcome studies (10-12). MI has now been learned and implemented by 
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practitioners of diverse professions, including medical providers (13-15), and appears durable up 
to 1-year post treatment (16).   
Reviews of MI cover mostly mental health outcomes; when medical outcomes have been 
targeted, outcomes generally result from studies outside of primary care settings (15-24). Taken 
together, these reviews yield odds ratios for MI treatments in the 1.5 range (a 50% benefit) 
versus patients who do not receive MI. A systematic review of MI delivered in physical health 
care settings has been conducted (25), though no known meta-analysis has been conducted on 
MI within medical settings. Our study seeks to fill this gap, as a meta-analysis uniquely provides 
a broad perspective and bird‘s eye view of the value of a specific treatment, which can then be 
used to focus future individual-level research. 
Our study investigated whether MI holds true potential as a treatment option alongside or within 
the delivery of routine medical care. This review is the first to focus explicitly on the effects of 
MI delivered in general medical care settings across a range of problem behaviors. Accordingly, 
the aims of this study are threefold: (1) clarify the general efficacy of MI in medical care 
settings; (2) ascertain whether MI effects in medical care are moderated by medical problem 
type, delivery (e.g., treatment setting, dose of MI, provider MI training), patient characteristics 
(e.g., ethnicity, gender, or age), or study design characteristics (e.g., methodological rigor); and 
(3) provide guidance for future research of MI in medical care settings. 
2. Method  
2.1 Study eligibility criteria 
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We followed PRISMA guidelines in conducting this study. Studies were included if they: used 
MI or motivational enhancement therapy (MET; MI plus feedback); employed a randomized trial 
that isolated MI‘s unique effect by comparing it to another group of patients who did not receive 
MI; and was conducted in a medical care setting such as a hospital, physician clinic, emergency 
department, medically-guided weight loss or diabetes center, dentist office, or physical therapy 
office. A study was excluded if: patients were consulting specifically for help with addictions or 
mental or behavioral health, as opposed to consulting for general medical conditions; it took 
place in an HIV specialty clinic (not a general medical center providing HIV treatment); MI was 
delivered only through a computer-based program without human contact; it was not published 
in English or in a peer-reviewed source. 
2.2. Information sources  
Research reports were identified from the following databases: PubMed, MedLine, CINAHL, 
Health Source: Nursing/Academic Edition, PsycARTICLES, PsycINFO, Scopus, Social Work 
Abstracts, Web of Knowledge; reports were also identified from an MI bibliography created by 
the Motivational Interviewing Network of Trainers (MINT; 26). The search spanned from 1983 
to August 2011.   
2.3. Search Strategy 
Search terms included: ‗motivational interview*‘ OR ‗motivational enhancement therapy.‘ See 
Figure 3.   
2.4. Data collection 
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Once the final group of studies was identified, all studies were independently coded by two 
authors. The average inter-rater reliability (kappa) was M = 0.84 (SD = 0.08) for the categorical 
moderators and M = 0.88 (SD = 0.09) for the continuous moderators, suggesting reliable coding.  
 
2.5 Coding articles 
The code sheet was designed to identify factors that may influence the efficacy of MI in medical 
care settings. These potential moderators were divided into three groups: (a) delivery of MI, (b) 
patient characteristics, and (c) study design.   
2.5.1. Delivery of MI 
2.5.1.1 Study location. MI was used in a variety of medical locations (see Table 2).   
2.5.1.2. Patient exposure to MI. Table 1 shows descriptive characteristics of included studies. 
The average time patients received MI was 106 minutes, longer than the 30 minute interventions 
for comparison groups. The mean number of sessions dedicated to delivering MI in a face-to-
face interaction was 2.6 (or 3.0 sessions of phone MI). 
2.5.1.2. Amount of provider MI training. The amount of MI training providers received (see 
Table 1). Providers spent an average of 18 hours learning MI, though there was a wide range (4 
to 40).  
2.5.1.3. Type of MI. Feedback was provided from standardized assessment instruments in MI 
style (i.e., MET) in 21 studies, whereas 30 studies delivered basic MI without problem feedback.  
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2.5.1.4. Provider. Who delivered MI (Table 4): mental health professionals (13 studies), nurses 
(6 studies), dieticians (3), physicians (2), or mixed provider types.  
2.5.1.5 Use of supervision toward fidelity. Whether studies supervised MI practice (36 studies) 
and, where available, how accurately the providers delivered MI (only 8 studies assessed MI 
treatment fidelity).   
2.5.2. Patient characteristics 
We also coded patient characteristic variables (Table 6): age, sex, ethnicity, and the stage of 
disease (i.e., primary, secondary, or tertiary prevention).  
2.5.3. Study Design 
2.5.3.1. Comparison group. Three broad types of comparison groups were employed: (1) 7 
studies used a traditional waitlist group, (2) 16 studies used information only groups, such as 
providing a brochure about obesity management or safe sex practices, and (3) 28 studies 
employed ―treatment-as-usual‖ conditions, which were heterogeneous and ranged from routine 
medical advice to cognitive behavioral treatments.  
2.5.3.2. Measurement type. We coded three measurement types: (1) 24 studies used biophysical 
indicators such as glycosylated haemoglobin tests for blood glucose control, Human 
Immunodeficiency Virus (HIV) viral load, Body Mass Index (BMI) for weight, or carbon 
monoxide or saliva cotinine verification of tobacco abstinence; (2) 12 studies used clinical 
records such as attending appointments or completing monitoring journals on diet; and/or (3) 44 
studies used self-report measures on topics such as quality of life (e.g., depression, confidence) 
or reports on behavior beliefs (e.g., safe sex behaviors).     
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2.5.3.3. Study rigor. Study rigor was assessed on an 18-point scale using criteria from existing 
assessment instruments and approaches such as the Cochrane system (27-29; code sheet 
available upon request). Each study was rated by two of the authors (BL, TM) on criteria such as 
number of participants, attrition, quality control, whether fidelity of MI delivery was assessed, 
objectivity of measurements, and reporting of follow-up data. Total rigor ratings ranged from 7 
to 17 in these studies (Table 1) and inter-rater reliability was high (r = 0.85). 
2.6. Outcomes 
In addition to the above moderators, the various medical outcomes assessed by individual studies 
were also treated as moderators. These outcomes, presented in Table 3, were grouped into the 
following 7 categories:   
 Prognostic markers 
 Disease endpoints 
 Risk reduction behaviors 
 Physical functioning and quality of life 
 Substance abuse 
 Patient adherence to medical advice and treatment protocols 
 Patient approach to change  
2.7. Effect size calculation and analytic strategy  
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The Odds Ratio was used as the primary effect size in this review. An OR of 1.0 suggests MI 
was equal to the comparison group, whereas an OR of 1.5 suggests that those in the MI group 
were one and a half times more likely to improve than those in the comparison group.  
A useful way to express ORs in meta-analyses is the Binomial Effect Size Display 
(BESD),which illustrates the practical importance of an effect by displaying it as a two-by-two 
contingency table [Group (MI, comparison) x Improvement (yes, no)] (30). This allows for 
calculation of percent improvement in each group. When MI outperformed the comparison 
group, the percent improved is above the 50% mark for MI and below 50% for the comparison 
group. The difference in percentages reflects the extent to which MI increases patient 
improvement relative to controls (30).   
Comprehensive Meta-Analysis software (31) was used to calculate ORs and run moderator 
analyses. All analyses were calculated at the 95% Confidence Interval (CI) level. A random 
effects model was used because our search strategy may not have captured all relevant studies 
(29). Regression analyses for continuously distributed moderators utilized the ―unrestricted 
maximum likelihood‖ method, which is similar to the random effects model (32).  
In meta-analysis, there are two possible ways to statistically combine outcomes. The first is to 
select only one effect size (―n‖) per study (―k‖); the second is to use all the available effect sizes 
(―n‖) even if several of them are derived from the same study (―k‖). Whereas multiple effect 
sizes derived from a single study are not technically independent, experts argue that running 
analyses at the effect size level is unlikely to cause biased estimates (33). Moreover, including 
multiple effect sizes from a particular study often serves to produce a more conservative estimate 
(34) as well as to optimize statistical power (35, 36). Thus, we reported summary statistics at the 
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effect size level when this allowed all data to be captured. For example, because some studies 
reported on more than one outcome (e.g., alcohol consumption and safe sex practices), analysis 
of MI‘s impact—both overall and by medical outcome category—was calculated at the effect 
size level. Conversely, moderator analyses were run at the study level because a given moderator 
was constant for all outcomes in that study. For example, the location in which MI was delivered 
in a particular study was the same regardless of outcomes assessed. In our study, ―n‖ is used 
when reporting effect-size level statistics and ―k‖ is used when reporting study-level statistics. 
(Note: Overall patterns did not differ when analyses were run at the study or effect size level).   
3. Results 
Our selection criteria yielded 48 unique studies with 51 comparisons and 332 effect sizes. This 
occurred because some studies had more than one comparison group and many studies reported 
multiple effect sizes by measuring multiple outcomes or the same outcome with multiple 
instruments and/or by repeatedly assessing outcomes across time. Across all studies, there were 
9,618 participants. To control for outlier effects (29), approximately 8% of the highest and 
lowest effect sizes were winsorized, leaving a total of 312 effect sizes for final analyses.   
Our results are organized around the three goals of meta-analyses: central tendency, variability, 
and prediction (37).   
3.1. Central tendency 
What was the overall magnitude of effect of motivational interviewing interventions? 
The omnibus effect size (OR) across the 51 comparisons and 312 effect sizes was statistically 
significant and positive for MI: OR = 1.55 (95% CI: 1.40 – 1.71), z = 8.67, p < .001. At the study 
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level, 63% of comparisons were positive and statistically significant at the p < .05 level, 10% had 
an OR below 1.0, although none was statistically significant. The remaining 27% of the studies 
showed a nonsignificant advantage for MI. The omnibus OR reveals that, on average, patients 
receiving MI were 1.55 times more likely to improve than those in the comparison groups. The 
BESD suggests that 56% of participants improved by having received MI whereas only 44% 
improved under the comparison conditions. The OR at the 25
th
 percentile was 1.00, 1.46 at the 
50
th
 percentile, and 2.36 at the 75
th
 percentile. Table 2 provides an overview of individual 
studies. Figure 1 provides a Forrest Plot of effect sizes at the study level.   
3.2. Variability 
Was the overall effect size stable?   
The omnibus effect size showed significant heterogeneity, Qw (311) = 521.68, p < .001; I-
squared = 90.42, suggesting a need for moderator analyses (below).   
3.3. Prediction 
Because we sought to examine the pragmatic question of MI‘s general effectiveness in medical 
care settings, the first moderator we explored was targeted medical outcomes, as shown in Table 
3. ORs varied significantly across these specific outcome categories, Qb (28) = 130.02, p < .001. 
3.3.1. How did MI effects vary by targeted outcomes?   
MI showed significant positive impact on three of five prognostic markers: blood pressure, 
cholesterol, and HIV viral load (but neither blood glucose nor heart rate). Two research groups 
studied the impact of MI on HIV viral load, which showed the strongest effect of all prognostic 
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markers. In terms of disease endpoints, MI lowered both dental caries and death compared with 
controls.  
MI also had positive and statistically significant effects on lowering the amount of alcohol 
consumed, decreasing dangerous alcohol consumption, increasing tobacco abstinence, and 
decreasing the amount of marijuana smoked. MI was applied to substance abuse within a 
medical care setting using several different time formats and provider types (see Table 2). These 
studies ranged from physicians providing 20 minutes of MI with follow-up phone calls in an 
emergency department setting with substance abusers (38) or a 15-minute MI intervention 
focused on alcohol and drug use following patient screening in a primary care clinic (39), to a 
psychologist meeting with patients for a series of meetings lasting about 150 minutes in a 
physician‘s clinic (40) or a nurse delivering three 15-minute MI sessions to patients identified as 
having hazardous drinking patterns (frequent use, binge drinking) in Thailand (41).
 
In most other targeted medical areas, MI produced mixed results. Regarding risk reduction 
behaviors, MI showed mainly non-significant results despite positive trends. MI had no 
significant effect in 20-minute sessions for injured adolescents who presented at an emergency 
department where the focus was to increase wearing seatbelts or bicycle helmets and decrease 
riding with a drunk driver (47). MI also did not have any significant impact on healthy eating, 
safe sex practices (e.g., condom use), fewer sexual partners, and reporting positive STD status to 
potential sex partners (42-44). MI showed a possible disadvantage in one study for eating 
disorder behaviors such as vomiting and laxative usage compared to CBT (45). However, MI did 
yield a statistically significant impact on body weight in 10 studies as measured by BMI, weight, 
and waist circumference.  
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The results related to MI‘s impact on physical functioning and other quality of life indicators 
were mixed. MI patients did not achieve statistically significant greater functional independence 
following a stroke relative to those in a comparison condition (47, 48). However, patients in an 
MI condition enjoyed statistically significantly better outcomes on physical strength and 
disability-related behaviors targeted by physical therapy compared to those who participated in 
physical therapy without MI (46). Six research groups assessed other quality of life indicators 
(46-51) including worry, anxiety, depression, pain, and adjustment to diseases such as diabetes, 
stroke, and chronic heart failure, which together showed a statistically significant advantage for 
MI.   
In terms of adherence to medical advice, MI had a statistically significant effect on patients‘ self-
monitoring, which included actions such as monitoring blood-sugar levels and food intake, as 
well as on encouraging non-sedentary behavior, such as increasing exercise, strength training, 
and reducing television watching. MI produced a statistically increase in patients‘ sense of 
confidence about approaching change when dealing with conditions such as diabetes, 
cardiovascular problems, or smoking. In addition, those in MI conditions were significantly more 
likely to keep appointments, participate in treatment, and report increased intention to change. 
However, MI did not yield significant results when applied to recommendations regarding breast 
feeding (52) and did not outperform control groups when applied to self-care activities for 
managing epilepsy (53) or following heart failure (54). MI also had mixed impact on medication 
adherence, an important component of behavioral medicine: MI promoted compliance to ART 
medication among HIV patients (55) and had a strong impact on lowering the overuse of 
prescriptions for pain and discomfort, although this benefit disappeared at the 1-year follow-up 
(55). Conversely, MI did not improve medication adherence among people with epilepsy (53).   
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3.3.2. What other variables moderated MI outcomes?   
As shown in Table 4, MI did not have significantly different outcomes across eight medical 
settings, Qb = 5.46, (7), p = 0.60, or five typical provider types, Qb = 8.92, (4), p = 0.06. All 
sites showed significantly positive outcomes for MI, with the exception of settings that also 
provided treatment for HIV. Although each provider type produced positive outcomes, only 
mental health providers and mixed teams reached statistical significance. Whereas MI was 
delivered more often by non-physicians, physicians also appeared effective in the two studies 
wherein they delivered MI. No consistent advantage was found from offering MET (OR = 1.79, 
k = 21; CI: 1.34 – 2.40) compared to typical MI (OR = 1.21, k = 30; CI: 1.21 – 1.6), Qb (1) = 
1.72, p = 0.19. Finally, reported supervision of MI delivery (OR = 1.64, k = 36; CI: 1.34 – 2.06) 
did not produce an advantage when compared to studies that did not report supervision (OR = 
1.39, k = 15; CI: 1.12 – 1.72), Qb (1) = 1.26, p = 0.26. Interestingly, studies assessing MI fidelity 
showed significantly lower impact (OR = 1.12, k = 8, CI: 0.96 – 1.2) relative to those that did not 
assess fidelity (OR = 1.72, k = 43; CI: 1.44 – 2.07, Qb (1) = 13.70, p < .001). All studies 
assessing fidelity indicated high adherence to the MI model.   
In terms of study design, comparison group did not moderate MI outcomes but measurement 
type and follow-up period did. MI showed the strongest effects when compared to waitlist no-
treatment groups (OR = 1.91, k = 7; CI: 1.38 – 2.64); however, this value did not statistically 
differ from information-only groups (OR = 1.54, k = 16; CI: 1.29 – 1.83) or treatment-as-usual 
groups (OR = 1.49, k = 28; CI: 1.34 – 1.71), overall Qb (2) = 1.81, p = 0.41. The measurement 
method did moderate MI outcomes: Effect sizes for biophysical indicators were lowest (OR = 
1.18, k = 24; n = 78; CI: 1.09 – 1.28), followed by records (OR = 1.48, k = 12, n = 30; CI: 1.24 – 
1.78), with self-report indicators yielding the highest effects (OR = 1.69, k = 44, n = 204; CI: 
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1.55 – 1.84, Qb (2) = 33.66, p < .001). Further analyses revealed biophysical measures were 
significantly lower than both self-report indicators (Qb = 33.28, p < .001) and records (Qb = 
4.88, p < .05), which did not differ significantly from each other (Qb = 1.56, p = 0.27.  
Results related to durability were mixed (see Table 5), with significant variance between 
different time points, Qb (3) = 29.35, p < .001. Within a 1-year time frame, MI‘s impact showed 
ORs in the 1.30 to 1.70 range. Of the 5 studies that examined MI beyond 13 months, the OR 
dropped to 1.14 which was significantly lower than effects 7-12 months after treatment (Qb = 
4.53, p < .05) and 5 weeks to 6 months after treatment (Qb = 28.54, p < .001). However, 
differences between MI‘s effects immediately following treatment and beyond 13 months were 
not statistically significant (Qb = 3.25, p > .06), and MI yielded significant positive effects 
beyond 13 months.  
In terms of patient characteristics, stage of disease did not significantly moderate MI effects: 
primary-prevention (OR = 1.38, k = 4; CI: 1.14 – 1.68), secondary-prevention (OR = 1.32, k = 7; 
CI: 1.05 – 1.68) or tertiary-prevention (OR = 1.54; k = 36; CI: 1.42 – 1.76), Qb (2) = 1.83, p = 
0.43. 
Continuous moderators bearing on outcomes were also examined via meta-regression (see Table 
6). Provider training time, patient age, sex, and ethnicity, and study rigor were not significantly 
associated with MI outcome. Whereas the number of MI sessions provided in person or by phone 
was unrelated to outcome, the total amount of time patients received in MI interventions 
approached significance (p = .06) such that longer total treatment resulted in stronger MI effects.  
3.3.3. Was there evidence of publication bias?   
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No. In primary research, significant results are more likely to be published than nonsignificant 
results, which can positively skew systematic reviews (56).
 
We assessed the likelihood of 
publication bias using three accepted methods. Rosenthal‘s Fail-safe N test indicated that 5604 
additional studies with null results not included in the meta-analysis would be needed to make 
the overall MI effect non-significant. Orwin‘s Fail-safe N, a more conservative test (31), 
indicated that 185 studies with null results would render the omnibus effect non-significant. Both 
numbers are large considering the number of included studies in this review (k = 48). Figure 2 
shows a Funnel Plot of the Standard Error, which is symmetrical. These three pieces of evidence 
converge to suggest publication bias is not problematic in this study.    
4. Discussion and Conclusions  
4.1 Discussion 
This is the first systematic review and meta-analysis of the efficacy of MI across medical care 
settings. Overall, MI showed beneficial effects, with 63% of main outcome comparisons in these 
studies yielding statistically significant advantages favoring MI. The omnibus OR suggests a 
55% increased chance of MI producing a positive outcome relative to comparison interventions, 
which were mostly treatment-as-usual groups (55%) or waitlist (14%) or information-only 
controls (31%).      
MI produced a statistically significant and positive impact on a range of outcome measures of 
interest to medical providers, including dental caries, death rate, cholesterol level, blood 
pressure, HIV viral load, body weight, physical strength, quality of life, amount of alcohol 
consumed, dangerous drinking, smoking abstinence, marijuana use, self-monitoring, sedentary 
behavior, patient confidence, intention to change, and engagement in treatment. However, MI 
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did not show a statistically significant effect on safe sex behaviors, heart rate, blood glucose, 
healthy eating, eating disorder behavior, injury prevention, functional independence post-stroke, 
marijuana abstinence, medication adherence, self-care, or breast feeding.  
Moderator analyses suggest MI is robust. MI is deliverable with or without assessment feedback 
by different types of medical providers, regardless of amount of training or supervision, across a 
wide variety of medical settings to patients with differing demographic characteristics and stages 
of disease. In fact, the only moderators that significantly accounted for differential effect sizes 
were targeted medical outcome type, measurement type (with self-report measures showing the 
strongest effects), fidelity (inversely), and, to a certain extent, dosage of MI. Positive effects in 
these studies were durable, with statistically significant effect sizes found more than a year 
following intervention and no indication of publication bias.  
4.1.1. Limitations   
Some relevant studies may not have been identified or were excluded because of our tight 
inclusion criteria (57). Further, not including unpublished works may have biased the results 
even though our publication bias analyses suggest otherwise. Within included studies, several 
medical outcomes included few studies, making effect sizes estimates unstable. Further, it was 
often difficult to determine the type of intervention to which MI was compared. Also, only eight 
studies assessed fidelity of MI delivery, calling into question what use of MI actually means. 
Fortunately, included studies had high external validity (i.e., they were in real-world clinics) and 
the mechanism of MI was not at issue here. As well, typically only 3.5% of studies assess fidelity 
adequately across the broad field of psychotherapy research (58).   
4.1.2 Comparison with other findings 
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To date, four general meta-analyses of MI across problem types and settings have been published 
(15, 17, 18, 19). These included studies outside of medical care settings and provide strong 
evidence that treatment outcomes for patients receiving MI interventions are superior to 
comparison interventions (OR of about 1.4 to 1.5). The present study found an omnibus OR of 
1.55 (95% CI 1.40-1.71) for MI in medical care, which is similar to the ORs found in these 
general reviews. Thus, MI works just as well in medical care settings as in the substance abuse 
and specialty clinics.   
Four further meta-analyses for MI in specific problem areas have been published. One on 
problem drinking (20) included 15 studies and yielded an OR of 1.66 (95% CI 1.53 to 4.66). In 
the current study, we found an even higher OR for MI with alcohol use of around 2.00 (95% CI 
from 1.33 to 3.06), indicating this remains one of MI‘s most appropriate targets and perhaps even 
most opportune within medical care settings. Two recent meta-analyses of MI and smoking have 
been conducted: One (22) yielded an OR for MI of 1.45 (95% CI 1.14 to 1.83) and the other (23) 
an OR of 1.35 (95% CI 1.02 to 1.78), both similar to our OR of 1.34 (95% CI 1.05 to 1.70) for 
MI on smoking abstinence.  
The newest published meta-analysis of MI targeted obesity (24). This review included 11 studies 
wherein 50 to 323 minutes of MI were typically employed as an adjunct to standard dietary care 
or, in about half the studies, a behavioral weight management program. Combined OR for weight 
loss, blood pressure reductions, and/or increases in physical activity was a high but non-
significant 1.90 (95% CI .99 to 3.53) for MI compared to standard care. With a larger number of 
studies, we found significant positive effects for MI in each of those areas separately: ORs of 
1.47 (95% CI 1.19 to 1.81) for exercise, 1.17 (95% CI 1.09 to 1.27) for weight loss, and 1.65 
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(95% CI 1.24 to 2.19) for blood pressure reductions. Thus, obesity represents a key medical 
domain in which MI is likely to be valuable. 
4.2 Conclusion 
The central implication of our findings is that MI can profitably be delivered by a range of 
professionals with a minimum investment of time in medical care settings in a variety of formats 
and time frames for patients of different ages, genders, and ethnicities. Our review suggests 
medical providers can use MI to help patients exercise more, lose weight, lower HIV viral load, 
blood pressure and cholesterol, reduce problematic substance use (perhaps even more effectively 
than in non-medical settings), and boost self-efficacy in their ability to make health-related 
behavioral changes.  
4.3. Practice Implications 
MI researchers have come a long way toward understanding its mechanism of action—a 
supportive relationship combined with the evocation of patient change talk (59). However, 
understanding why MI failed to impact some but not other medical outcomes is complex. The 
simplest explanation is that the low number of studies in certain problem areas resulted in 
positive but non-significant effect sizes for MI; in fact, with one exception, all targeted outcomes 
not yielding significant effects had fewer than four studies. The exception was in the area of 
healthy eating, where MI failed to produce any discernible advantage across 6 studies. Upon 
closer scrutiny, the 3 effects sizes contributing most heavily to the non-significant effect for MI 
came from two studies which did not include face-to-face contact between MI providers and 
patients. One (60)
 
used only web-based MI that relied upon email and the relied only on 
telephone MI (61). 
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Another important target for which MI did not produce measurable benefits overall was 
medication adherence. For example, MI did not improve medication adherence for patients with 
epilepsy (53)
 
but it did for those with HIV-AIDS (62) and at 3-month but not 1-year follow-up 
for prescription drug abusers (55, 63). Again, the study not yielding significant effects for MI 
utilized a telephone-only format (53).
 
It would therefore be premature to conclude that MI is not 
worth using to bolster medication adherence or healthy eating until further research is conducted 
with face-to-face treatment.  
In examining moderators, fidelity was inversely related to outcome such that studies measuring 
MI fidelity produced lower effect sizes (OR = 1.19) than those that did not (OR = 1.64). This 
may be cause for sobering reflection, as studies producing the strongest effects may or may not 
have been faithfully delivering MI as designed. However, this finding could also indicate that MI 
is easy to implement in real-world settings and has positive effects for patients even without 
time-intensive supervision or fidelity monitoring. Future studies that seek to explain findings or 
add to intervention refinement and development should conduct thorough process evaluations.  
Another interesting finding relates to the duration of patient exposure to MI. Whereas the total 
amount of time participants received MI interventions approached significance (p = .06) the 
number of MI sessions was unrelated to outcome, suggesting that longer time in a single MI visit 
may promote better outcomes. Providers may need to invest slightly more time in each visit to 
realize the full benefits of MI. In a recent study of MI at a general medical clinic, MI training 
increased physician visit length by about 10% while producing significant reductions in patient 
depression (64).   
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What about the clinical significance? Overall, patients receiving MI had one and half times the 
chance of improving on a wide variety of health measures compared to control groups. The take 
home point is: No matter what your professional training or where you work, if you can devote a 
small amount of extra time with your patients to build relationship and evoke change talk, you 
can expect 10-15% (as per our BESD analyses above) additional improvement across a wide 
variety of behaviors and medical outcomes.  
  
  
 Motivational Interviewing in Medical Settings    23 
 
 
Declaration of Competing Interest 
 
All authors have completed the Unified Competing Interest form at 
www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and we 
declare that (1) none of the authors has support from an external source to produce this 
systematic review; (2) none of the authors have relationships with those that might have an 
interest in the submitted work in the previous 3 years; (3) their spouses, partners, or children do 
not have financial relationships that may be relevant to the submitted work; and (4) none of the 
authors have non-financial interests that may be relevant to the submitted work. 
 
 
The authors made the following contributions:  
 
Brad Lundahl PhD: Study design, searching and coding studies, analysis, writing 
Teena Moleni MSW: Study design, searching and coding studies, data base management, 
analysis, writing 
Brian Burke PhD, Rob Butters PhD, Derrik Tollefson PhD, Chris Butler MD, Stephen Rollnick 
PhD: Study design, analysis, writing 
 
Each author has access to the raw and computed data for each study insuring the integrity of the 





 Motivational Interviewing in Medical Settings    24 
 
References in Main Article (i.e., not from Table 2)   
 
1 Goldstein M, Whitlock E, DePue J. Multiple Behavioral Risk Factor Interventions in 
Primary Care: Summary of Research Evidence. Amer J Prev Med 2004; 27: 61-79. 
2 Mokdad A, Marks J, Stroup D, Gerberding J. Actual causes of death in the United States, 
 2000. J Amer Med Assoc 2004; 291: 1238-45. 
3 Rollnick S, Butler C, McCambridge J, Kinnersley P, Elwyn G, Resnicow K. 
Consultations about changing behaviour. Brit Med J 2005; 331: 961-3. 
4 Miller, W, Rollnick S. Motivational interviewing: Helping people change. 3rd Ed. New 
York: Guilford Press, 2013. 
5 Miller W. Motivational interviewing with problem drinkers. Beh Psychotherapy 1983; 
11: 147-72. 
6 Miller W, Rollnick S. Motivational interviewing: Preparing people to change addictive 
behavior. New York: Guilford Press, 1991.  
7 Miller W, Rollnick S. Motivational interviewing: Preparing people for change. 2nd ed. 
New York: Guilford Press; 2002. 
8 Miller W, Benefield R, Tonigan J. Enhancing motivation for change in problem drinking: 
A controlled comparison of two therapist styles. J Consult Clin Psychology 1993; 61: 
455-61. 
9 Miller W, Sovereign R, Krege B. Motivational interviewing with problem drinkers: II. 
The Drinker's Check-up as a preventive intervention. Beh Psychotherapy 1988; 16: 251-
68. 
10 Rollnick S, Miller W, Butler C. Motivational Interviewing in Healthcare. New York: 
Guilford Press, 2008. 
 Motivational Interviewing in Medical Settings    25 
 
11 Rollnick S, Mason P, Butler C.  Health behavior change: A guide for practitioners.  
Edinburgh: Churchill Livingstone, 1999. 
12 Rollnick S, Butler C, Kinnersley P, Gregory J, Mash B. Motivational interviewing. Brit 
Med J (Overseas & Retired Doctors Edition) 2010; 340: 1242-45. 
13 Miller W, Yahne C, Moyers T, Martinez J, Pirritano M. A Randomized Trial of Methods 
to Help Clinicians Learn Motivational Interviewing. J  Consul Clin Psychology 2004; 72: 
1050-62. 
14 Keeley R, Brody D, Burke B. Cluster-randomized trial of teaching primary care 
clinicians motivational interviewing to improve depression treatment 2012; Manuscript in 
Preparation. 
15 Lundahl B, Kunz C, Brownell C, Tollefson D, Burke B. A Meta-Analysis of Motivational 
Interviewing: Twenty-Five Years of Empirical Studies. Research Social Work Practice 
2010; 20: 137-60. 
16 Lundahl B, Burke B. The effectiveness and applicability of motivational interviewing: a 
practice-friendly review of four meta-analyses. J Clin Psychology 2009; 65: 1232-45. 
17 Burke B, Arkowitz H, Menchola M. The efficacy of motivational interviewing: A meta-
analysis of controlled clinical trials. J Consult Clin Psychology 2003; 71: 843-61. 
18 Hettema J, Steele J, Miller W. Motivational Interviewing. Ann Rev Clin Psychology 
2005; 1: 91-111. 
19 Rubak S, Sandbaek A, Lauritzen T, Christensen B. Motivational interviewing: a 
systematic review and meta-analysis. Brit J Gen Pract 2005; 55: 305-12. 
 Motivational Interviewing in Medical Settings    26 
 
20 Vasilaki E, Hosier S, Cox W. The efficacy of motivational interviewing as a brief 
intervention for excessive drinking: A meta-analytic review. Alcohol & Alcoholism 2006; 
41: 328-35. 
21 Matching alcoholism treatments to client heterogeneity: Project MATCH Posttreatment 
drinking outcomes. J Studies Alcohol 1997; 58: 7-29. 
22 Heckman C, Egleston B, Hofmann M. Efficacy of motivational interviewing for smoking 
cessation: a systematic review and meta-analysis. Tobacco Control 2010; 19: 410-16. 
23 Hettema J, Hendricks P. Motivational Interviewing for Smoking Cessation: A Meta-
Analytic Review. J Consul Clin Psychology 2010; 78: 868-84. 
24 Armstrong M, Mottershead T, Ronksley P, Sigal R, Campbell T, Hemmelgarn B. 
Motivational interviewing to improve weight loss in overweight and/or obese patients: a 
systematic review and meta-analysis of randomized controlled trials. Obesity Reviews: 
2011; 12: 709-23.  
25 Knight K, McGowan L, Dickens C, Bundy C. A systematic review of motivational 
interviewing in physical health care settings. Brit J Health Psychology 2006; 11: 319-32. 
26 MINT. Motivational Interviewing Network of Trainers. Bibliography page. 2009. 
 www.motivationalinterviewing.org 
27 Higgins J, Green S. Cochrane Handbook for Systematic Reviews of Interventions 
Version 5.1.0. www.cochrane-handbook.org. The Cochrane Collaboration; 2011 
28 Cooper H, Hedges L, Valentine J. The handbook of research synthesis and meta-analysis. 
2nd ed. New York: Russell Sage Foundation, 2009. 
29 Lipsey, M, Wilson, D. Practical meta-analysis. London: Sage, 2000. 
 Motivational Interviewing in Medical Settings    27 
 
30 Randolph, J, Edmondson, R. Using the binomial effect size display (BESD) to present the 
magnitude of the effect sizes to the evaluation audience. Practical Assess Research Eval 
2005; 10, 1–7. 
31 Borenstein M, Hedges L, Higgins J, Rothstein H. Comprehensive Meta Analysis. 2nd ed. 
New Jersey: Biostat, 2005. 
32 Morton S, Adams J, Suttorp M, et al. Meta-regression Approaches: What, Why, When, 
and How? Rockville (MD): Agency for Healthcare Research and Quality (US); 2004 
Mar. (Technical Reviews, No. 8.). See: www.ncbi.nlm.nih.gov/books/NBK43894/ 
33 Hunter, J, Schmidt, Schmidt, F. Methods of meta-analysis: Correcting error and bias in 
research findings. 2nd ed. Newbury Park, CA: Sage, 2004. 
34 Borenstein M, Hedges L, Higgins J, Rothstein H. Comprehensive Meta Analysis. 2nd ed. 
New Jersey: Biostat, 2005. 
35 Hedges L, Pigott T. The Power of Statistical Tests for Moderators in Meta-Analysis. 
Psychological Methods 2004; 9: 426-45. 
36 O'Mara, A, Marsh, H. An application of multilevel modelling to meta-analysis and 
comparison with traditional approaches. Paper presented at the 6th International 
Amsterdam Multilevel Conference, University of Utrecht, Amsterdam, The Netherlands. 
(2007, April). 
37 Johnson B, Mullen B, Salas E. Comparison of three major meta-analytic approaches. J 
Applied Psychology 1995; 80(1): 94-106. 
38 Johnston B, Rivara F, Droesch R, Dunn C, Copass M. Behavior change counseling in the 
emergency department to reduce injury risk: a randomized, controlled trial. Pediatrics 
2002; 110: 267-74. 
 Motivational Interviewing in Medical Settings    28 
 
39 D'Amico E, Miles J, Stern S, Meredith L. Brief motivational interviewing for teens at risk 
of substance use consequences: A randomized pilot study in a primary care clinic. J  
Substance Abuse Treat 2008; 35: 53-61. 
40 Emmen M, Schippers G, Wollersheim H, Bleijenberg G. Adding Psychologist's 
Intervention to Physicians' Advice to Problem Drinkers in the Outpatient Clinic. Alcohol 
& Alcoholism 2005; 40: 219-26.   
41 Noknoy S, Rangsin R, Saengcharnchai P, Tantibhaedhyangkul U, McCambridge J. RCT 
of Effectiveness of Motivational Enhancement Therapy Delivered by Nurses for 
Hazardous Drinkers in Primary Care Units in Thailand. Alcohol & Alcoholism 2010; 45: 
263-70.   
42 Chacko M, Wiemann C, Kozinetz C, von Sternberg K, Velasquez M, DiClemente R, et 
al. Efficacy of a motivational behavioral intervention to promote chlamydia and 
gonorrhea screening in young women: a randomized controlled trial. J Adolescent Health 
2010; 46: 152-61. 
43 Naar-King S, Wright K, Parsons J, Frey M, Templin T, Murphy D, et al. Healthy choices: 
motivational enhancement therapy for health risk behaviors in HIV-positive youth. AIDS 
Educ Prevent 2006; 18: 1-11.   
44 Naar-King S, Lam P, Wang B, Wright K, Parsons J, Frey M. Brief report: maintenance of 
effects of motivational enhancement therapy to improve risk behaviors and HIV-related 
Health in a randomized controlled trial of youth living with HIV. J Ped Psychology 2008; 
33: 441-45.  
45 Katzman M, Bara-Carril N, Rabe-Hesketh S, Schmidt U, Troop N, Treasure J. A 
randomized controlled two-stage trial in the treatment of bulimia nervosa, comparing 
 Motivational Interviewing in Medical Settings    29 
 
CBT versus motivational enhancement in Phase 1 followed by group versus individual 
CBT in Phase 2. Psychosomatic Med 2010; 72: 656-63. 
46 Vong S, Cheing G, Chan F, So E, Chan C. Motivational enhancement therapy in addition 
to physical therapy improves motivational factors and treatment outcomes in people with 
low back pain: a randomized controlled trial. Arch Physical Med Rehab 2011; 92: 176-
83. 
47 Watkins C, Auton M, Deans C, Dickinson H, Jack C, Leathley M, et al. Motivational 
interviewing early after acute stroke: a randomized, controlled trial. Stroke: J Cerebral 
Circulation 2007; 38: 1004-09. 
48 Watkins C, Wathan J, Leathley M, Auton M, Deans C, Lightbody C, et al. The 12-month 
effects of early motivational interviewing after acute stroke: a randomized controlled 
trial. Stroke: J Cerebral Circulation 2011; 42: 1956-61. 
49 Ismail K, Thomas S, Maissi E, Chalder T, Schmidt U, Treasure J, et al. Motivational 
enhancement therapy with and without cognitive behavior therapy to treat type 1 
diabetes: a randomized trial. Annals of Internal Med 2008; 149: 708-19. 
50 Brodie D, Inoue A, Shaw D. Motivational interviewing to change quality of life for 
people with chronic heart failure: a randomised controlled trial. Intern J Nurs Studies 
2008; 45: 489-500. 
51 Rosenbek Minet L, Wagner L, Lønvig E, Hjelmborg J, Henriksen J. The effect of 
motivational interviewing on glycaemic control and perceived competence of diabetes 
self-management in patients with type 1 and type 2 diabetes mellitus after attending a 
group education programme: a randomised controlled trial. Diabetologia 2011; 54: 1620-
29. 
 Motivational Interviewing in Medical Settings    30 
 
52 Wilhelm S, Stepans M, Hertzog M, Rodehorst T, Gardner P. Motivational Interviewing 
to Promote Sustained Breastfeeding. J Obstetric, Gynecologic, & Neonatal Nursing 
2006; 35: 340-48.  
53 Dilorio C, Reisinger E, Yeager K, McCarty F. A telephone-based self-management 
program for people with epilepsy. Epilepsy & Beh 2009; 14: 232-36. 
54 Paradis V, Cossette S, Frasure-Smith N, Heppell S, Guertin M. The efficacy of a 
motivational nursing intervention based on the stages of change on self-care in heart 
failure patients. J Cardiovascular Nurs 2010; 25: 130-41.   
55 Zahradnik A, Otto C, Crackau B, Löhrmann I, Bischof G, Rumpf H, et al. Randomized 
controlled trial of a brief intervention for problematic prescription drug use in non-
treatment-seeking patients. Addiction 2009; 104: 109-17. 
56 Ferguson C, Brannick M. Publication bias in psychological science: Prevalence, methods 
for identifying and controlling, and implications for the use of meta-analyses. 
Psychological Methods 2012; 17: 120-28. 
57 Heather N, Rollnick S, Bell A, Richmond R.  Effects of brief counselling among heavy 
drinkers identified on general hospital wards. Drug Alcohol Rev 1996; 15: 29-38.  
58 Perepletchikova F, Treat T, Kazdin A. Treatment integrity in psychotherapy research: 
Analysis of the studies and examination of the associated factors. Journal of Consulting 
and Clinical Psychology 2007; 75: 829-841. 
59 Miller W, Rose G. Toward a theory of motivational interviewing. Amer Psychologist 
2009; 64: 527-37. 
 Motivational Interviewing in Medical Settings    31 
 
60 Alexander G, McClure J, Calvi J, Divine G, Stopponi M, Johnson C, et al. A Randomized 
Clinical Trial Evaluating Online Interventions to Improve Fruit and Vegetable 
Consumption. Amer J Pub Health 2010; 100: 319-26. 
61 Campbell M, Carr C, DeVellis B, Switzer B, Biddle A, Sandler R, et al. A Randomized 
Trial of Tailoring and Motivational Interviewing to Promote Fruit and Vegetable 
Consumption for Cancer Prevention and Control. Annals Beh Med 2009; 38: 71-85. 
62 Golin C, Earp J, Tien H, Stewart P, Porter C, Howie L. A 2-arm, randomized, controlled 
trial of a motivational interviewing-based intervention to improve adherence to 
antiretroviral therapy (ART) among patients failing or initiating ART. J Acquired 
Immune Deficiency Syndromes 2006; 42: 42-51. 
63 Otto C, Crackau B, Löhrmann I, Zahradnik A, Bischof G, John U, Rumpf HJ. Brief 
intervention in general hospital for problematic prescription drug use: 12-month outcome. 
Drug Alcohol Depend 2009; 105: 221-6. 
64 Keeley, R, deGruy, F, Thomas, M, Brody, D, Burke, B. Motivational Interviewing for 
Depression in Primary Care: Training and Pilot Outcomes. Proceedings of the North 
American Primary Care Research Group (NAPCRG) conference: 2011, November 
14).Seattle, WA. 
 
References from Table 2: Articles included in the study ―*‖  
*Ahluwalia J, Okuyemi K, Nollen N, Choi W, Kaur H, Mayo M, et al. The effects of nicotine 
gum and counseling among African American light smokers: a 2 × 2 factorial design. Addiction 
2006; 101: 883-91.  
 Motivational Interviewing in Medical Settings    32 
 
*Alexander G, McClure J, Calvi J, Divine G, Stopponi M, Johnson C, et al. A randomized 
clinical trial evaluating online interventions to improve fruit and vegetable consumption. Amer J 
Pub Health 2010; 100: 319-26.   
*Bernstein E, Edwards E, Dorfman D, Heeren T, Bliss C, Bernstein J. Screening and brief 
intervention to reduce marijuana use among youth and young adults in a pediatric emergency 
department. Academic Emerg Med 2009; 16: 1174-85.   
*Bowen D, Ehret C, Pedersen M, Snetselaar L, Johnson M, Williams Beedoe J, et al. Results of 
an Adjunct Dietary Intervention Program in the Women's Health Initiative. J  Amer Dietetic 
Assoc 2002; 102: 1631-37.   
*Brodie D, Inoue A, Shaw D. Motivational interviewing to change quality of life for people with 
chronic heart failure: a randomised controlled trial. Intern J Nursing Studies 2008; 45: 489-500.   
*Brug J, Spikmans F, Aartsen C, Breedveld B, Bes R, Fereira I. Training dietitians in basic 
motivational interviewing skills results in changes in their counseling style and in lower 
saturated fat intakes in their patients. J Nutrition Educ Beh 2007; 39: 8-12.   
*Campbell M, Carr C, DeVellis B, Switzer B, Biddle A, Sandler R, et al. A Randomized Trial of 
Tailoring and Motivational Interviewing to Promote Fruit and Vegetable Consumption for 
Cancer Prevention and Control. Annals Beh Med 2009; 38: 71-85.   
*Chacko M, Wiemann C, Kozinetz C, von Sternberg K, Velasquez M, DiClemente R, et al. 
Efficacy of a motivational behavioral intervention to promote chlamydia and gonorrhea 
screening in young women: a randomized controlled trial. J  Adolescent Health 2010; 46: 152-
61.   
*Colby S, Monti P, Tevyaw T, Barnett N, Spirito A, Lewander W, et al. Brief motivational 
intervention for adolescent smokers in medical settings. Addictive Behaviors 2005; 30: 865-74.   
 Motivational Interviewing in Medical Settings    33 
 
*D'Amico E, Miles J, Stern S, Meredith L. Brief motivational interviewing for teens at risk of 
substance use consequences: A randomized pilot study in a primary care clinic. J  Substance 
Abuse Treat 2008; 35: 53-61.   
*DiIorio C, Reisinger E, Yeager K, McCarty F. A telephone-based self-management program for 
people with epilepsy. Epilepsy & Behavior 2009; 14: 232-36.   
*Emmen M, Schippers G, Wollersheim H, Bleijenberg G. Adding Psychologist's Intervention to 
Physicians' Advice to Problem Drinkers in the Outpatient Clinic. Alcohol Alcoholism 2005; 40: 
219-26.   
*Ershoff D, Quinn V, Boyd N, Stern J, Gregory M, Wirtschafter D. The Kaiser Permanente 
prenatal smoking-cessation trial: when more isn't better, what is enough? Amer J Prevent Med 
1999; 17: 161-68.  
*Gentilello L, Rivara F, Donovan D, Jurkovich G, Daranciang E, Ries R, et al. Alcohol 
interventions in a trauma center as a means of reducing the risk of injury recurrence. Annals 
Surgery 1999; 230: 473-80.   
*Golin C, Earp J, Tien H, Stewart P, Porter C, Howie L. A 2-arm, randomized, controlled trial of 
a motivational interviewing-based intervention to improve adherence to antiretroviral therapy 
(ART) among patients failing or initiating ART. J Acq Immune Deficiency Syndromes 1999; 42: 
42-51.   
*Habib S, Morrissey S, Helmes E. Preparing for pain management: a pilot study to enhance 
engagement. J  Pain 2005; 6: 48-54.   
*Hardcastle S, Taylor A, Bailey M, Castle R. A randomised controlled trial on the effectiveness 
of a primary health care based counselling intervention on physical activity, diet and CHD risk 
factors. Patient Educ Couns 2008; 70: 31-9.   
 Motivational Interviewing in Medical Settings    34 
 
*Hillsdon M, Thorogood M, White I, Foster C. Advising people to take more exercise is 
ineffective: a randomized controlled trial of physical activity promotion in primary care. 
International J Epidemiology 2002; 31: 808-15.   
*Ismail K, Thomas S, Maissi E, Chalder T, Schmidt U, Treasure J, et al. Motivational 
enhancement therapy with and without cognitive behavior therapy to treat type 1 diabetes: a 
randomized trial. Annals Internal Med 2008; 149: 708-19.   
*Johnston B, Rivara F, Droesch R, Dunn C, Copass M. Behavior change counseling in the 
emergency department to reduce injury risk: a randomized, controlled trial. Pediatrics 2002; 110: 
267-74.   
*Katzman M, Bara-Carril N, Rabe-Hesketh S, Schmidt U, Troop N, Treasure J. A randomized 
controlled two-stage trial in the treatment of bulimia nervosa, comparing CBT versus 
motivational enhancement in Phase 1 followed by group versus individual CBT in Phase 2. 
Psychosomatic Med 2010; 72: 656-63.   
*Lloyd-Richardson E, Stanton C, Papandonatos G, Shadel W, Stein M, Niaura R, et al. 
Motivation and patch treatment for HIV+ smokers: a randomized controlled trial. Addiction 
2009; 104: 1891-1900. 
*Magill M, Barnett N, Apodaca T, Rohsenow D, Monti P. The role of marijuana use in brief 
motivational intervention with young adult drinkers treated in an emergency department. J 
Studies Alcohol Drugs 2009; 70: 409-13.   
*Maisto S, Conigliaro J, McNeil M, Kraemer K, Conigliaro R, Kelley M. Effects of two types of 
brief intervention and readiness to change on alcohol use in hazardous drinkers. J Studies 
Alcohol 2001; 62: 605-14.   
 Motivational Interviewing in Medical Settings    35 
 
*Mhurichu C, Margetts B, Speller V. Randomized clinical trial comparing the effectiveness of 
two dietary interventions for patients with hyperlipidaemia. Clinical Science 1998; 95: 479-87. 
*Naar-King S, Wright K, Parsons J, Frey M, Templin T, Murphy D, et al. Healthy choices: 
motivational enhancement therapy for health risk behaviors in HIV-positive youth. AIDS 
Education & Prevention 2006; 18: 1-11.   
*Naar-King S, Lam P, Wang B, Wright K, Parsons J, Frey M. Brief report: maintenance of 
effects of motivational enhancement therapy to improve risk behaviors and HIV-related Health 
in a randomized controlled trial of youth living with HIV. J  Ped Psych 2008; 33: 441-45. 
*Noknoy S, Rangsin R, Saengcharnchai P, Tantibhaedhyangkul U, McCambridge J. RCT of 
Effectiveness of Motivational Enhancement Therapy Delivered by Nurses for Hazardous 
Drinkers in Primary Care Units in Thailand. Alcohol & Alcoholism 2010; 45: 263-70. 
*Otto C, Crackau B, Löhrmann I, Zahradnik A, Bischof G, John U, Rumpf HJ. Brief intervention 
in general hospital for problematic prescription drug use: 12-month outcome. Drug Alcohol 
Depend 2009; 105: 221-6. 
*Paradis V, Cossette S, Frasure-Smith N, Heppell S, Guertin M. The efficacy of a motivational 
nursing intervention based on the stages of change on self-care in heart failure patients. J  
Cardiovascular Nursing 2010; 25: 130-41. 
*Rosenbek Minet L, Wagner L, Lønvig E, Hjelmborg J, Henriksen J. The effect of motivational 
interviewing on glycaemic control and perceived competence of diabetes self-management in 
patients with type 1 and type 2 diabetes mellitus after attending a group education programme: a 
randomised controlled trial. Diabetologia 2011; 54: 1620-29.   
*Rubak S, Sandbaek A, Lauritzen T, Christensen B. Motivational interviewing: a systematic 
review and meta-analysis. Brit J Gen Practice 2005; 55: 305-12. 
 Motivational Interviewing in Medical Settings    36 
 
*Schermer C, Moyers T, Miller W, Bloomfield L. Trauma center brief interventions for alcohol 
disorders decrease subsequent driving under the influence arrests. J Trauma 2006; 60: 29-34.   
*Senft R, Polen M, Freeborn D, Hollis J. Brief intervention in a primary care setting for 
hazardous drinkers. Amer J Preventive Medicine 1997; 13: 464-70.   
*Smith D, Krati P, Heckemeyer C, Mason D.  Motivational interviewing to improve adherence 
to a behavioral weight-control program for older obese women with NIDDM – A pilot study.  
Diabetes Care. 1997; 20: 52-54. 
*Soares de Azevedo R, Mauro M, Lima D, Gaspar K, da Silva V, Botega N. General hospital 
admission as an opportunity for smoking-cessation strategies: a clinical trial in Brazil. Gen 
Hospital Psychiatry 2010; 32: 599-606.  
*Soria R, Legido A, Escolano C, Yeste A, Montoya J.  A randomized controlled trial of 
motivational interviewing for smoking cessation. British J Gen Practice 2006 October 1; 56: 
768–74. 
*Stotts A, DiClemente C, Dolan-Mullen P. One-to-One: A motivational intervention for resistant 
pregnant smokers. Addictive Behav 2002; 27: 275-92.   
*van Voorhees B, Fogel J, Pomper B, Marko M, Reid N, Domanico R, et al. Adolescent dose 
and ratings of an internet-based depression prevention program: A randomized trial of primary 
care physician brief advice versus a motivational interview. J Cognitive & Behavioral 
Psychotherapies 2009; 9: 1-19.   
*Vong S, Cheing G, Chan F, So E, Chan C. Motivational enhancement therapy in addition to 
physical therapy improves motivational factors and treatment outcomes in people with low back 
pain: a randomized controlled trial. Arch Phys Med Rehab 2011; 92: 176-83.   
 Motivational Interviewing in Medical Settings    37 
 
*Watkins C, Auton M, Deans C, Dickinson H, Jack C, Leathley M, et al. Motivational 
interviewing early after acute stroke: a randomized, controlled trial. Stroke: J Cerebral 
Circulation 2007; 38: 1004-09. 
*Watkins C, Wathan J, Leathley M, Auton M, Deans C, Lightbody C, et al. The 12-month 
effects of early motivational interviewing after acute stroke: a randomized controlled trial. 
Stroke: J Cerebral Circulation 2011; 42: 1956-61. 
*Weinstein P, Harrison R, Benton T. Motivating parents to prevent caries in their young 
children: one-year findings. J Amer Dental Assoc 2004; 135: 731-38.   
*Weinstein P, Harrison R, Benton T. Motivating mothers to prevent caries: confirming the 
beneficial effect of counseling. J Amer Dental Assoc 2006; 137: 789.   
*West D, DiLillo V, Bursac Z, Gore S, Greene P. Motivational interviewing improves weight 
loss in women with type 2 diabetes. Diabetes Care 2007; 30: 1081-87.   
*Wilhelm S, Stepans M, Hertzog M, Rodehorst T, Gardner P. Motivational Interviewing to 
Promote Sustained Breastfeeding. J Obstetric, Gynecologic, & Neonatal Nursing: Clinical 
Scholarship for The Care Of Women, Childbearing Families, & Newborns 2006; 35: 340-48.   
*Wu D, Ma G, Zhou K, Zhou D, Liu A, Poon A. The effect of a culturally tailored smoking 
cessation for Chinese American smokers. Nicotine & Tobacco Research 2009: 11: 1448-57.   
*Zahradnik A, Otto C, Crackau B, Löhrmann I, Bischof G, Rumpf H, et al. Randomized 
controlled trial of a brief intervention for problematic prescription drug use in non-treatment-
seeking patients. Addiction 2009; 104: 109-17.   
 
 










K  Mean (SD)          Median  Min / Max  
_____________________________________________________________________________ 
 
Total minutes in treatment   
MI    43 106.01 (92.39)  79.00            15 - 480 min 
Comparison/Waitlist  40   29.98 (72.39)   0.00  0 - 300 min  
 
Face-to-face sessions 
MI    45     2.60 (1.95)    3.00            1 – 10 sessions 
 
Phone sessions 
MI    20     3.00 (1.92)    2.50            0 – 7 sessions 
 
Hours to train providers in MI 24   17.92 (11.39) 18.00            4 – 40 hours 
 
Rigor rating of studies   51   12.51 (2.59)  12.50            7 – 17 
_________________________________________________________________________ 
 
Note. K = number of studies contributing data. OR = Odds Ratio. SD = Standard Deviation. 
Three studies delivered MI via phone without face-to-face interactions; 17 studies utilized a 








Overview of studies 
____________________________________________________________________________________________________________ 
 
Study (first author only) Setting   Targeted outcomes   OR   Limits          p-value           n’s 
     95%                           MI / Comp  
____________________________________________________________________________________________________________ 
Ahluwalia (2006)  Community health Tobacco    0.98 0.86 / 1.12 0.730       189 / 189  
Alexander (2010)  Cancer network Eating fruits, vegetables  0.98 0.85 / 1.13 0.740       661 / 671 
Bernstein (2009)  Emergency Dept Marijuana     2.80 1.85 / 4.26 0.001*       47 / 55 
Bowen (2002)   Women Hlth Center    Eating: energy from fat  2.33 1.50 / 3.63 0.001*       82 / 82 
Brodie (2008)   Hospital  Chronic heart failure: life quality 7.57 5.14 / 11.14 0.001*       22 / 18 
Brug (2007)   Home health  Diabetes: eating, weight  1.33 1.04 / 1.71 0.023*       83 / 59 
> Campbell x WL (2007) Cancer network Eating fruits, vegetables  1.13 0.86 / 1.49 0.893       109 / 120 
>Campbell x TAU (2007) Cancer network Eating fruits, vegetables  1.08 0.82 / 1.43 0.579       109 / 110 
Chacko ( 2010)  Primary care  Safe sex practices   1.30 0.88 / 1.90 0.186         90 / 78 
Colby (2005)   Hospital  Tobacco    1.29 1.02 / 1.64 0.036*       43 / 42 
D’Amico (2008)  Primary care  Alcohol, marijuana   3.20 1.97 / 5.20 0.001*       20 / 22 
Dilorio (2009)   Epilepsy clinic Self-management, confidence 1.18 0.72 / 1.92 0.512         10 / 10 
Emmen (2005)  Primary care  Alcohol    1.16 0.78 / 1.74 0.456         61 / 62 
Ershoff (1999)  Prenatal care  Tobacco use during pregnancy  1.00 0.75 / 1.35 0.984       101 / 111 
Gentilello (1999)  Emergency Dept Injury prevention   1.21 1.01 / 1.44 0.034*     205 / 205 
Golin (2006)   HIV disease clinic Adherence to Antiretroviral tx 1.58 1.00 / 2.49 0.049*       49 / 52 
Habib (2005)   Primary care etc Self-management: pain    4.18 1.60 / 10.94 0.004*       39 / 39 
Hardcastle (2008)  Primary care  Diet, physical activity: obesity 1.30 1.16 / 1.46 0.001*     203 / 131 
>Hillsdon x TAU (2002) Primary care  Exercise, heart-rate, BMI  1.23 1.07 / 1.41 0.003*     177 / 319 
>Hillsdon x WL (2002) Primary care  Exercise    1.55 1.11 / 2.17 0.010*     177 / 178 
Ismail (2008)   Hospital  Diabetes: blood glucose; self mgmt 1.11 0.98 / 1.26 0.088       121 / 117 
Johnston (2002)  Emergency Dept Injury prevention   1.25 1.05 / 1.47 0.010*     234 / 238 
Katzman (2010)  Hospital/Eating D/O Eating disorder; binge; laxative 0.69 0.42 / 1.14 0.150         28 / 17 
Lloyd-Richardson (2009) Primary care + Tobacco among HIV + group  0.02 0.58 / 1.42 0.655       116 / 113 
Magill (2009)   Emergency dept Marijuana    3.07 2.01 / 4.69 0.001*       25 / 33 
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>Maisto x TAU (2001) Primary care  Alcohol     3.90 3.15 / 4.82 0.001*       73 / 85     
>Maisto x TAU (2001) Primary care  Alcohol     2.34 1.82 / 3.02 0.001*       73 / 85 
Mhurchu (1998)  Hospital diet clinic Cholesterol, BMI   0.97 0.70 / 1.33 0.827         47 / 50 
Naar-King (2006)  Hospital: HIV clinic HIV viral load; drugs; safe sex, etc 2.43 1.41 / 4.20 0.001*       19 / 26 
Naar-King (2008)  Hospital: HIV clinic HIV viral load; drugs; safe sex, etc 1.84 1.09 / 3.10 0.022*       22 / 25 
Noknoy (2010)  Primary care  Alcohol: hazardous drinkers  2.51 2.09 / 3.03 0.001*       50 / 48 
Otto (2009)   Hospital  Prescription drug adherence  1.05  0.83 / 1.33 0.699         56 / 56 
Paradis (2010)   Hospital  Heart failure: self-care, efficacy 1.62 0.84 / 3.15 0.153         12 / 13 
Rosenbek Minet (2011) Hospital: diabetes BMI, Cholesterol, heart rate, etc 1.05 1.00 / 1.10 0.069       149 / 149 
Rubak (2009)   Primary care  Diabetes: engagement in self-care 1.18 1.06 / 1.32 0.003*     133 / 132   
Schermer (2006)  Emergency dept Alcohol: dangerous drinking  2.20 0.82 / 5.89 0.117         64 / 62 
Sentf (1997)   Primary care  Alcohol    1.26 1.12 / 1.42 0.001*     196 / 215     
Smith (1997)   Other: Diabetes Diabetes self-care, weight, GHb,etc 6.16 2.92 / 13.00 0.001*         6 / 10 
Soares de Azevedo (2010) Hospital  Tobacco    1.47 1.25 / 1.74 0.001*     107 / 108 
Soria (2006)   Primary care  Tobacco    6.25  2.59 / 15.07 0.001*     114 / 86   
Stotts (2002)   Hospital  Tobacco: pregnant smokers  1.03 0.75 / 1.43 0.841         82 / 84 
Van Voorhees (2009)  Primary care  Depression: engagement in tx 2.08 1.30 / 3.35 0.002*       42 / 43 
Vong (2011)   Physical therapy Strength, adherence, life quality 1.92 1.33 / 2.77 0.001*       38 / 38 
Watkins (2007)  Hospital: Stroke Fxn independence, mortality, etc 1.18 1.01 / 1.37 0.041*     172 / 167    
Watkins (2011)  Hospital: Stroke Fxn independence, mortality, etc 1.18 0.99 / 1.40 0.071         18 / 12 
Weinstein (2004)  Dental practice Preventing caries     1.74 1.10 / 2.77 0.019*     119 / 119 
Weinstein (2006)  Dental practice Preventing caries     2.01 1.15 / 3.53 0.015*     103 / 102 
West (2007)   Other: Diabetes Weight, GHb, self-care, reporting 1.58 1.41 / 1.77 0.001*     103 / 92   
Wilhelm (2005)  Hospital  Breastfeeding    1.48 0.73 / 3.01 0.273         34 / 28 
Wu (2009)   Home health  Tobacco, confidence   1.68 1.35 / 2.08 0.001*       60 / 62 
Zahradnik (2009)  Hospital  Prescription medicine adherence 2.21 1.22 / 4.00 0.009*       55 / 62 
_______________________________________________________________________________________________________ 
Note: Comp = Comparison Group; Fxn = functional; Hlth = health; MI = Motivational Interviewing Group; STD = Sexually 
transmitted disease; WL = Waitlist; tx = treatment; TAU = Treatment as Usual.  
* p < .05;  >  = Study has two comparison groups. 
All studies are located in the 2
nd
 reference section with a “*” by the first author’s name. 
 Motivational Interviewing in medical settings   4 
 
  
Table 3  
 
MI Effects: Overall and by Medical Outcome Category 
 _____________________________________________________________________________________________________ 
 
                    BESD 
Targeted Outcome  k  (n)  OR            CI         z-        Hetero-              % Improved               





   Omnibus effect  51 (312)  1.55**     1.40 / 1.71      8.67      Yes   56    44  
 
Targeted Medical Outcomes 
 
  Prognostic markers     
 
   Blood Glucose    5 (12)  1.17      0.82 / 1.67      0.85          Yes   52     48     
   Blood Pressure    1   (02)  1.65**      1.24 / 2.19      3.45        No    57       43 
   Cholesterol     3 (12)  1.09*      1.00 / 1.19      1.92       No  51     49    
   Heart rate     2   (06)  1.00      0.87 / 1.14     -0.02            No  50     50    




   Dental (carries)    2 (02)  1.85**      1.29 / 2.64      3.36            No    58     42   
   Death rate      3 (03)  1.87*      1.03 / 3.40      2.06            No  59     41   
 
Risk reduction behaviors 
 
    Safe sex behavior    3 (06)  1.42      0.99 / 2.03       1.89         No  55     45  
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    Eating healthy    6 (12)  1.16      0.94 / 1.43       1.39          Yes  52     48 
    Eating disorder behavior   1  (06)  0.74      0.39 / 1.40       -0.94            No  46     54   
    Injury prevention     1 (10)  1.28      0.97 / 1.69       1.71            No  53     47 
    Body weight  10 (19)  1.17**      1.09 / 1.27       4.22            No  52     48    
 
Physical functioning and quality of life 
 
   Physical strength     1 (02)  1.78*      1.00 / 3.18       1.95          No  58     42  
   Functional independence 
 (post stroke)    2 (06)  1.09      0.87 / 1.36       0.73     No  51     49  
   Quality of life    6  (21)  2.21**      1.65 / 2.96       5.28**  Yes   62     38 
 
Substance use 
    Alcohol      
       Amount     9 (38)  2.31**      1.75 / 3.06      5.86 Yes   61     39   
       Dangerous Use    4 (16)  1.83**      1.33 / 2.53      3.69 Yes             58     42  
 
   Smoking Tobacco    
       Abstinence    8 (38)  1.34*      1.05 / 1.70      2.38 Yes    54     46   
       Amount     4 (12)  1.18      0.96 / 1.45      1.59 Yes   52     48   
 
   Marijuana        
       Amount     5 (11)  3.22**      2.14 / 4.84      5.60 Yes    65     35  
       Abstinence    1 (02)  1.99      0.81 / 4.86      1.51 No    60     50   
 
Adherence to medical advice/protocol  
 
    Self monitoring     4 (13)  2.14**      1.65 / 2.79      5.67 Yes    61     39 
    Medication adherence  4 (10)  1.25      0.95 / 1.65       1.61 No   53     47  
    Self care    2 (05)  0.64      0.33 / 1.27     -1.27 No    44     56 
    Sedentary behavior    5 (07)  1.47**      1.19 / 1.81      3.62 Yes   55     45 
    Breast feeding   1 (02)  1.48          0.73 / 3.01      1.10 No  55     45 
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Approach to change and treatment 
 
   Confidence / efficacy  7   (17)  1.39**      1.09 / 1.78      2.63 Yes    55     45     
   Intention to change   5 (05)   1.97**      1.11 / 3.48       2.53  No    59     41   





Note. Tx = Treatment.  
K = number of studies. OR = Odds Ratio. CI = 95% confidence interval.  
n = effect sizes contributing to Odds Ratio and associated statistics   
Heterogeneity: “Yes” or “No” reflects significance based on I-squared values.   
% Improved based on BESD (Randolph & Edmondson, 2005).   
“Difference” column was calculated by % Improved MI Group minus % Improved Comparison Group   
HIV = Human Immunodeficiency Virus 








Table 4  
 








                      % Improved 
            MI / C 
Delivery Site 
  Dental clinic   2     2 1.85**    1.29 / 2.64 3.36  .001 No 58 / 42  
  Emergency Department 5     23 1.83**    1.27 / 2.64 3.24  .001 Yes 59 / 41 
  Clinic with HIV treatment  3     11 1.57   0.86 / 2.86 1.47  .142 No 56 / 44 
  Home health   2   18 1.51*   1.21 / 1.89 3.61  .001 Yes 56 / 44 
  Hospital              16 120 1.39*   1.16 / 1.66 3.56  .001 Yes 55 / 45 
  Physical therapy  1       5 1.92*   1.33 / 2.77 3.46  .001 No 59 / 41 
  Physician office / clinic           16   98 1.69*   1.39 / 2.05       5.27  .001 Yes 58 / 42 
 
Provider Type 
  Dietician   3  14 1.41   0.92 / 2.15 1.56 .118 Yes 55 / 45 
  Physician   2    6 2.56   0.50 / 13.05 1.13 .259 Yes 62 / 38  
  Mental health professional      13  73 1.73*   1.42 / 2.10       5.53 .001 Yes 58 / 42 
  Mixed                            9  68 1.23*   1.08 / 1.40 3.11 .002 Yes 55 / 45  




Note. k = number of studies; n = number of effect sizes derived from each setting. Some studies could not 
be reliably coded into a single category. Hetro = Heterogeneity. BESD = Binomial Effect Size Display. 
MI = Motivational Interviewing condition. C = Comparison Condition.   













Durability   k   n OR Limits    z     p        Hetro           BESD    
_____________________________________________________________________________ 
 
                  % Improved 
                    MI / C  
 
Immediate – 1 month 13   47 1.38**   1.16 / 1.65   3.61   .001     Yes  55 / 45 
5 weeks – 6 months  29 163 1.72**   1.55 / 1.91 10.30   .001   Yes  58 / 42 
7 – 12 months  21   85 1.34**   1.22 / 1.48   5.85    .001   Yes  55 / 45 
13 + months    5   17   1.14*   1.03 / 1.28   2.40   .016   Yes  52 / 48 
_____________________________________________________________________________ 
 
Note. k = number of studies; n = number of effect sizes derived from each setting. Some studies 
could not be reliably coded into a single category. Hetro = Heterogeneity. BESD = Binomial 
Effect Size Display. MI = Motivational Interviewing condition. C = Comparison Condition.   








Potential Continuous Moderators of MI effects 
____________________________________________________________________________ 
Moderator      k z-value p       Slope / Intercept  
_____________________________________________________________________________ 
 
Degree of exposure to MI 
     Number of MI counselling sessions: in person 44    0.76  .45 .03 / .47 
     Number of MI counselling sessions: via phone 18  - 0.54  .16     - .03 / .43 
     Total minutes of MI intervention   42   1.90  .06 .00 / .34  
 
Provider training in MI 
     Total minutes spent training provider in MI 23   0.17  .86 .01 / .25    
 
Patient characteristics  
     Patient average age    46   0.18  .85 .00 / .42     
     % of Caucasians in sample (USA only):  29 - 0.46  .65 .00 / .48     
     % of males in sample    37   0.94  .35 .00 / .35     
 
Study quality 
     Study rigor rating     50 - 0.04  .97 .00 / .52 
 
______________________________________________________________________________ 
Note. k = number of studies. As not all studies contributed data for all moderators, k is often less 
than 54.  
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Figure 1 




Study name Statistics for each study Odds ratio and 95%  CI
Odds Lower Upper 
ratio limit limit Z-Value p-Value
Ahluwalia (2006) 0.412 0.257 0.662 -3.671 0.000
Alexander (2010) 0.970 0.798 1.179 -0.304 0.761
Bernstein (2009) 2.894 1.224 6.842 2.421 0.015
Bowen (2002) 1.000 0.301 3.319 0.000 1.000
Brodie (2008) 17.853 4.893 65.142 4.364 0.000
Brug (2007) 2.409 1.304 4.451 2.807 0.005
Campbell (2007; waitlist) 1.574 0.981 2.524 1.882 0.060
Campbell (2007; TAU) 1.070 0.662 1.730 0.277 0.782
Chacko (2010) 1.418 0.759 2.647 1.096 0.273
Colby (2005) 2.865 1.304 6.296 2.620 0.009
D'Amico (2008) 4.268 0.457 39.842 1.273 0.203
Dilorio (2009) 4.943 0.935 26.132 1.881 0.060
Emmen (2005) 0.964 0.508 1.831 -0.111 0.912
Ershoff (1999) 0.905 0.470 1.742 -0.300 0.764
Gentilello (1999) 1.215 1.019 1.449 2.171 0.030
Golin (1999) 1.379 0.630 3.018 0.803 0.422
Habib (2005) 4.182 1.599 10.938 2.917 0.004
Hardcastle (2008) 1.486 0.997 2.216 1.944 0.052
Hillsdon (2002; TAU) 1.646 1.127 2.406 2.578 0.010
Hillsdon (2002; waitlist) 1.552 1.111 2.168 2.577 0.010
Ismail (2008) 0.921 0.581 1.461 -0.348 0.728
Johnston (2002) 1.700 1.133 2.549 2.565 0.010
Katzman (2010) 0.533 0.120 2.374 -0.825 0.409
Lloyd-Richardson (2009) 0.913 0.417 1.998 -0.229 0.819
Magill (2009) 11.343 4.005 32.126 4.572 0.000
Maisto (2001; TAUa) 13.171 6.983 24.841 7.963 0.000
Maisto (2001; TAUb) 1.244 0.692 2.238 0.730 0.465
Mhurichu (1998) 1.052 0.511 2.167 0.139 0.890
Rosenbek-Minet (2011) 1.116 0.908 1.371 1.044 0.297
Naar-King (2006) 1.324 0.468 3.750 0.529 0.597
Naar-King (2008) 1.939 0.658 5.720 1.200 0.230
Noknoy (2010) 1.796 0.871 3.700 1.587 0.113
Otto (2009) 1.139 0.814 1.595 0.759 0.448
Paradis (2010) 6.166 1.362 27.905 2.361 0.018
Rubak (2005) 1.036 0.833 1.289 0.319 0.750
Schermer (2006) 2.200 0.822 5.890 1.569 0.117
Senft (1997) 1.312 0.923 1.865 1.515 0.130
Smith (1997) 1.860 0.293 11.809 0.658 0.511
Soares de Azevedo (2010) 1.139 0.664 1.954 0.472 0.637
Soria (2006) 6.247 1.798 21.705 2.883 0.004
Stotts (2002) 0.674 0.282 1.611 -0.888 0.374
van Voorhees (2009) 1.941 0.760 4.954 1.387 0.165
Vong (2011) 4.290 1.838 10.016 3.367 0.001
Watkins (2007) 0.992 0.647 1.520 -0.037 0.971
Watkins (2011) 1.607 0.103 24.964 0.339 0.734
Weinstein (2004) 1.740 1.095 2.766 2.342 0.019
Weinstein (2006) 2.012 1.148 3.526 2.441 0.015
West (2007) 2.299 1.371 3.854 3.158 0.002
Wilhelm (2006) 1.412 0.461 4.320 0.604 0.546
Wu (2009) 1.094 0.575 2.082 0.273 0.785
Zahradnik (2009) 2.448 1.147 5.224 2.315 0.021
1.579 1.357 1.836 5.929 0.000
0.01 0.1 1 10 100
Favours Control Favours M.I.
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Figure 2 





















Funnel Plot of Standard Error by Log odds ratio
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Optional Figure     








Studies included in meta-analysis 
(n = 48) 3 studies employed 2 
comparison groups each, yielding a 
total of 51 unique comparisons.  
Full-text articles secured and 
assessed for eligibility  
(n = 352) 
Records excluded based 
on review of title and 
abstract  
(n = 1131) 
Records after duplicates removed and screened: 
(n = 1483) 
MINT database 
26
   
(n = 168) 
 
Database searching: 
(n = 5551) 
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